Jeronimo Rodriguez-Cid
10PUBLICATIONS
65CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Aug 22, 2024
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.James Chih-Hsin Yang, Dae Ho Lee, Jong-Seok Lee
|Aug 06, 2024
Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico.Denisse Añorve Bailon, Javier Picó-Guzmán, Sergio Cifuentes
|Feb 03, 2023
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.Silvia Novello, Dariusz M Kowalski, Alexander Luft
|Dec 04, 2022
Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas.Jeronimo Rafael Rodriguez-Cid, Juan Jose Juarez-Vignon Whaley, Gisela Sánchez-Domínguez
|Aug 19, 2021
A comparative study of immunotherapy as second-line treatment and beyond in patients with advanced non-small-cell lung carcinoma.Jerónimo Rafael Rodríguez-Cid, Sonia Carrasco-Cara Chards, Iván Romarico González-Espinoza
Pageof 2
Frequent Collaborators
2 joint publications
José Fabián Martínez-Herrera
2 joint publications
Juan Jose Juarez-Vignon Whaley
2 joint publications
Ki Hyeong Lee
2 joint publications
Martin Reck
2 joint publications
Oscar Arrieta
1 joint publications
Rodrigo Riera-Sala
1 joint publications
Jordi Guzmán-Casta
1 joint publications
Denisse Añorve Bailon
1 joint publications
Javier Picó-Guzmán
1 joint publications
Gary J Doherty